Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Preferred Shares (2017 - 2020)

Aytu Biopharma has reported Preferred Shares over the past 4 years, most recently at $981.0 for Q1 2020.

  • Quarterly Preferred Shares rose 319.23% to $981.0 in Q1 2020 from the year-ago period, while the trailing twelve-month figure was $981.0 through Mar 2020, up 319.23% year-over-year, with the annual reading at $359.0 for FY2019, N/A changed from the prior year.
  • Preferred Shares was $981.0 for Q1 2020 at Aytu Biopharma, down from $1022.0 in the prior quarter.
  • Over five years, Preferred Shares peaked at $1022.0 in Q4 2019 and troughed at $1.0 in Q3 2017.
  • The 4-year median for Preferred Shares is $337.0 (2019), against an average of $420.75.
  • Year-over-year, Preferred Shares soared 45200.0% in 2018 and then skyrocketed 125.61% in 2019.
  • A 4-year view of Preferred Shares shows it stood at $1.0 in 2017, then soared by 45200.0% to $453.0 in 2018, then skyrocketed by 125.61% to $1022.0 in 2019, then dropped by 4.01% to $981.0 in 2020.
  • Per Business Quant, the three most recent readings for AYTU's Preferred Shares are $981.0 (Q1 2020), $1022.0 (Q4 2019), and $315.0 (Q3 2019).